Patient-focused precautions, testing help blunt pandemic effects on heme-onc unitMay 26, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersLung CancerMixed Topics
Secondary acute lymphoblastic leukemia more lethal than de novoMay 14, 2020HematologyOncologyLeukemia, Myelodysplasia, Transplantation
Six million childhood cancer deaths could be prevented over the next 30 yearsApril 23, 2020OncologyHematologyLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Will coronavirus restrictions lead to more advanced cancers?April 23, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Cancer care ‘transformed in space of a month’ because of pandemicApril 17, 2020Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Blood test might detect multiple cancer types, study suggestsMarch 31, 2020OncologyMixed TopicsLung CancerHematologyHead & Neck/Thyroid CancersLymphoma & Plasma Cell DisordersGenitourinary Cancer
CLL and breast cancer differ in the expression of regulatory microRNAsMarch 25, 2020Breast CancerOncologyHematology
New CAR T-cell therapy eliminates MM and tumor propagating cells without fratricide in lab studyFebruary 26, 2020Multiple MyelomaHematologyOncology